ArticleBreast cancer research : BCR2020

Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.